-
Leaders Exchanging Jibes: Highlights Of NATO Summit in London
Thursday, December 5, 2019 - 7:17am | 461Read More...The North Atlantic Treaty Organization summit ended in London on Wednesday, with the leaders of the allied countries taking plentiful jibes at each other throughout the summit. The U.S. President Donald Trump, of course, led the pack. “Very, Very Nasty” Macron Ahead of the summit, Trump...
-
Mallinckrodt Reports Better-Than-Expected Q1, Raises Guidance
Tuesday, February 2, 2016 - 8:54am | 263Read More...Shares of Mallinckrodt PLC (NYSE: MNK) were trading higher by nearly 6 percent early Tuesday morning after the company reported its first quarter results. Mallinckrodt earned $2.09 per share in the first quarter on revenue of $914.80 million. Wall Street analysts were expecting the company to...
-
Mallinckrodt CEO Responds To Citron Allegations: 'We Are Playing The Long Game With' Acthar
Tuesday, November 10, 2015 - 12:07pm | 359Read More...Shares of Mallinckrodt PLC (NYSE: MNK) continued to tumble on Tuesday after falling 17 percent and being halted several times in Monday’s session. The decline was triggered by a tweet from Citron Research, which read, "At these prices $MNK has signif more downside than $VRX-- far...
-
The FDA's Authority Challenged By Mallinckrodt
Friday, May 15, 2015 - 3:07pm | 471Read More...The American healthcare system became much more affordable with the advent of generic drugs. Many popular medications have lower-costing, alternative treatments that contain the same active ingredients as their costly brand-name rivals, which has saved the public millions in pharmaceutical costs....
-
Mallinckrodt Falls 7% On Adverse FDA News
Thursday, November 13, 2014 - 11:17am | 330Read More...Mallinckrodt plc (NYSE: MNK) released a press release Thursday after it was informed by the U.S. Food and Drug Administration that the agency has reason to believe that the company’s methylphenidate hydrochloride extended-release (ER) tablets, USP (CII) may not be therapeutically equivalent...
